Form 4: Nexxen CFO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Nexxen International Ltd. CFO Niri Sagi has sold shares under a pre-arranged trading plan, indicating a planned divestment strategy.

Summary

  • Niri Sagi, Chief Financial Officer of Nexxen International Ltd., reported a transaction involving common stock.
  • The transaction, dated July 6, 2026, involved the sale of 199 shares at a price of $9.54 per share.
  • This sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025.
  • Following the transaction, Niri Sagi beneficially owns 331,831 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about adverse non-public information.

Negatives

  • The CFO of Nexxen International Ltd. has sold shares, which could be perceived negatively by the market, although it was conducted under a pre-planned trading strategy.

Risks

  • The sale of shares by a key executive, even under a 10b5-1 plan, can sometimes be interpreted as a lack of confidence in the company's future prospects by the market.
  • While the sale is part of a pre-established plan, the specific timing and amount could still influence investor sentiment.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The Rule 10b5-1 plan indicates a pre-determined strategy for future transactions, but specific details beyond the plan's existence are not provided.

Management Comments

  • The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025.

Industry Context

StockSavvy.ai notes that Form 4 filings, particularly those involving sales by C-suite executives, are closely watched by investors. The use of a Rule 10b5-1 plan is a standard mechanism for insiders to sell shares without triggering insider trading concerns, suggesting a planned divestment rather than a reaction to negative company news.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyA Power of Attorney was established, appointing specific individuals to act on behalf of the undersigned (Niri Sagi) for executing Section 16 and Form 144 filings.03/11/2026Ensures compliance with SEC filing requirements by delegating the execution of necessary forms to authorized personnel.

Stakeholder Impact

  • Shareholders: May view the sale with caution, although the Rule 10b5-1 plan provides some reassurance against negative insider sentiment.
  • Management: Demonstrates adherence to compliance procedures for stock transactions.
  • Employees: Similar to shareholders, the impact is likely minimal due to the planned nature of the sale.

Next Steps

  • Monitor future Form 4 filings for any additional transactions by Niri Sagi or other Nexxen International Ltd. executives.
  • Observe the company's stock performance and any subsequent disclosures for further context.

Key Dates

DateDescription
08/19/2025Date the Rule 10b5-1 trading plan was adopted by Niri Sagi.
03/11/2026Date the Power of Attorney was executed.
07/06/2026Transaction date for the sale of common stock.
07/08/2026Date the Form 4 was signed by the reporting person.

Recommendation

hold

The filing reports a routine stock sale by the CFO under a pre-established 10b5-1 plan. This type of transaction, while involving insider selling, is designed to avoid signaling adverse non-public information. Without other negative indicators in the filing or broader company news, a 'hold' recommendation is appropriate, suggesting investors maintain their current position pending further developments.

Keywords

Nexxen International Ltd., NEXN, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, CFO, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.